杜仲抗骨质疏松药效物质基础及机制研究-药剂学专业论文.docx

杜仲抗骨质疏松药效物质基础及机制研究-药剂学专业论文.docx

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
杜仲抗骨质疏松药效物质基础及机制研究-药剂学专业论文

RT-PCR 方法对成骨细胞 TRACP 因子考察发现,京尼平苷酸能浓度依赖性的抑 制 TRACP 因子的活性。结论:杜仲 40%乙醇组分是促成骨细胞增殖及分化成 熟活性组分,该组分中的化合物紫云英苷、黄芩苷、京尼平苷酸和咖啡酸是杜 仲抗骨质疏松的活性成分。京尼平苷酸、紫云英苷、黄芩苷、咖啡酸具有显著 性的提高成骨细胞分化成熟的能力并且京尼平苷酸还能抑制成骨细胞转化为破 骨细胞,维持成骨细胞与破骨细胞的平衡。同时京尼平苷酸、紫云英苷、黄芩 苷、咖啡酸能上调 OPG/RANKL 系统改善骨重建;紫云英苷、黄芩苷加强钙离 子与骨组织的结合能力辅助改善骨重建以到达改善骨质疏松症的目的。综上所 述,本研究初步阐明了杜仲药材抗骨质疏松的药效物质基础,并对其抗骨质疏 松的机制进行了初步研究,为杜仲药材的开发应用提供了实验依据。 关键词:杜仲;骨质疏松;药效物质基础;机制研究 V Studies of pharmacodynamic material basis of Eucommia ulmoides Oliv Major: Pharmacy Master Candidate: Lan Bo Sipervisors: Li Yong-Jun Lan Yan-Yu [Abstract] Objective: the application of modern separation technology of Eucommia ulmoides were isolated and purified by the research methods and mechanism of pharmacology research Du Zhongkang osteoporosis. Methods: the chemical composition separation of Eucommia ulmoides by drilling resin adsorption method, use UPLC maps; Using the research methods of pharmacology, in vitro culture of MC3T3-E1 subclone 14 into bone cells and SAO-2 human osteoblasts, and study the effects of Eucommia ulmoides components of MC3T3-E1 subclone 14 into bone cells and SAO-2 human osteoblast cell survival rate, alkaline phosphatase activity, osteoprotegerin activity. Through the research of pharmacology, chemical components of Eucommia ulmoides in established HPLC (UPLC) map based on it. With the help of electrospray ionization - by ultra performance liquid chromatography tandem mass spectrometry (UPLC-ESI-MS/MS) combined with technology of Eucommia contributed to the proliferation of bone cell effective component research. Investigation of Eucommia compound on MC3T3-E1 subclone 14 into the survival rate of bone cells by pharmacology effect method, and application of real time fluorescent quantitative PCR and Western blot (Western blot) technology research at the molecular level of Eucommia compound on MC3T3-E1 subclone 14 in osteoblasts of OPG, RANKL, RUNX-2, expression of Osterix and TRACP gene and protein the change of the ratio of OPG/RANKL, investigation. A

您可能关注的文档

文档评论(0)

peili2018 + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档